Caveolin-1 loss of function accelerates glucose transporter 4 and insulin receptor degradation in 3T3-L1 adipocytes by González-Muñoz, Elena et al.
Caveolin-1 Loss of Function Accelerates Glucose
Transporter 4 and Insulin Receptor Degradation in
3T3-L1 Adipocytes
Elena Gonza´lez-Mun˜oz, Carmen Lo´pez-Iglesias, Maria Calvo, Manuel Palacín,
Antonio Zorzano, and Marta Camps
Departament de Bioquímica i Biologia Molecular (E.G.-M., M.P., A.Z., M.C.), Facultat de Biologia, Universitat de
Barcelona, Institute for Research in Biomedicine (IRB Barcelona) (E.G.-M., M.P., A.Z.), and Unitat de Reconeixement
Molecular (C.L.-I.), Serveis Cientifico-Te`cnics, Universitat de Barcelona, 08028 Barcelona, Spain; and Unitat de
Microsco`pia Confocal (M.C.), Serveis Cientifico-Te`cnics, Universitat de Barcelona, Facultat de Medicina, and Centro de
Investigación Biomédica en Red de Diabetes y Enfermedades Metabo´licas (CIBERDEM) (A.Z., M.C.), CIBERDEM
Asociadas, Mallorca 183, 08036 Barcelona, Spain
Caveolae are a specialized type of lipid rafts that are stabilized by oligomers of caveolin protein.
Caveolae are particularly enriched in adipocytes. Hereweanalyzed the effects of caveolin-1 knock-
down and caveolae ablation on adipocyte function. To this end, we obtained several multiclonal
mouse 3T3-L1 cell lines with a reduced expression of caveolin-1 (95% reduction) by a small inter-
feringRNAapproachusing lentiviral vectors. Control cell lineswereobtainedby lentiviral infection
with lentiviral vectors encoding appropriate scrambled RNAs. Caveolin-1 knockdown adipocytes
showed a drastic reduction in the number of caveolae (95% decrease) and cholera toxin labeling
was reorganized in dynamic plasma membrane microdomains. Caveolin-1 depletion caused a
specificdecrease inglucose transporter4 (GLUT4)and insulin receptorprotein levels. This reduction
was not the result of a generalized defect in adipocyte differentiation or altered gene expression
but was explained by faster degradation of these proteins. Caveolin-1 knockdown adipocytes
showed reductions in insulin-stimulatedglucose transport, insulin-triggeredGLUT4 recruitment to
the cell surface, and insulin receptor activation. In all, our data indicate that caveolin-1 loss of
function reducesmaximal insulin response through lowered stability anddiminished expression of
insulin receptors andGLUT4.Wepropose that caveolin-1/caveolae control insulin action in adipose
cells. (Endocrinology 150: 3493–3502, 2009)
Lipid rafts are lateral assemblies of sphingolipids and choles-terol that form a separate liquid-ordered phase in the liquid-
disordered matrix of the lipid bilayer (1). Lipid rafts function as
platforms with which distinct classes of proteins are associated,
such as glycosylphosphatidylinositol-anchored proteins, trans-
membrane proteins, and diacylated proteins.
Caveolae are a specialized type of lipid raft that appear in the
plasma membrane (PM) as 50- to 100-nm flask-shaped invagi-
nations.Caveolae functionhasbeenwidelydebatedandhasbeen
implicated in membrane traffic, signal transduction, substrate
transport, and endocytosis (2). Caveolae are present in most cell
types but are particularly abundant in adipocytes, where they
account for30%of thePMsurface area (3). In adipocytes, caveo-
lin-1 isoform is responsible for caveolae formation (4).
Adipose tissue plays a critical role in energy homeostasis in
higher organisms. It serves as the main site for energy storage in
the form of triglycerides and also contributes to systemic glucose
and lipid metabolism via its function as an endocrine organ. In
unstimulated basal adipocytes, less than 5% of glucose trans-
porter 4 (GLUT4) is in the PM. Insulin regulates glucose trans-
port in adipose tissue by increasing the amount of GLUT4 in the
PM. After insulin removal, GLUT4 is rapidly internalized from
the PM and is effectively sequestered within the cell, thus de-
creasing adipocyte glucose uptake.
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The characterization of the caveolin-1 knockout mouse phe-
notype associated, for the first time, caveolin-1/caveolae with
lipid homeostasis and obesity. Lisanti’s group (5) showed that
despite being hyperphagic, adult caveolin-1-null mice were lean
and resistant to diet-induced obesity and exhibited reduced fat
pads compared with wild-type littermates. Recently, it has been
reported that rare caveolin-1 frameshiftmutations are associated
withatypical lipodystrophyandhypertriglyceridemia (6, 7). Fur-
thermore, caveolin-1 gene expression is up-regulated in visceral
and sc white adipose tissue in obese nondiabetic or type 2 pa-
tients compared with lean controls (8).
Recently, the groups led by Pilch and Parton (9, 10) have
shown that cavin/polymerase I and transcript release factor, a
caveolae-associated protein, is an essential component of caveolae.
Mice lacking cavin have nomorphologically detectable caveolae in
any cell type examined and have markedly diminished protein ex-
pression of all three caveolin isoforms. Cavin knockout mice have
higher circulating triglyceride levels, reduced adipose tissue mass,
glucose intolerance, and hyperinsulinemia (11).
A role for caveolin-1 in insulin signaling and its potential
involvement in diabetes has been proposed (12). Young caveo-
lin-1 knockout mice fed a normal diet show a blunted response
to an insulin tolerance test (13). In further studies, it has been
demonstrated that caveolin-1 interactswith insulin receptor (IR)
and enhances insulin-mediated phosphorylation of IR substrate
1 (IRS-1) (14, 15). Caveolae integrity is required for IR signaling,
which leads to GLUT4 translocation to the PM (4, 4, 16–19).
Caveoale have been related toGLUT4 endocytosis. There are
data documenting the mediation of GLUT4 endocytosis by two
pathways, one clathrin dependent andanother onedependent on
cholesterol-enriched domains in adipocytes (20–23).
However, to analyze the function of caveolae in insulin-stim-
ulated GLUT4 translocation and GLUT4 endocytosis, choles-
terol-aggregating or -depleting reagents, such as filipin, nystatin,
and -methylcyclodextrin, have been used (17–19, 21, 24, 25).
These reagents do not discriminate between lateral noncaveolar
lipid rafts and invaginated caveolae, because both types of lipid
microdomains are sensitive to cholesterol depletion.
To analyze the effect of specifically disrupting caveolae mi-
crodomains, we repressed caveolin-1 protein in 3T3-L1 adipo-
cytes using the RNA interference method. Our results show that
caveolin-1 participates in GLUT4 and IR protein stability, thus
altering maximal insulin response stimulating glucose transport
of caveolin-1 knockdown (KD) adipocytes.
Materials and Methods
Antibodies
The following antibodies were used: anti-caveolin-1, anti-caveo-
lin-2, anti-flotillin-1, anti-IR -subunit, and anti-phosphotyrosine
(PY20) from Transduction Laboratories (Lexington, KY); anti-GLUT4
(OSCRX) (26), anti-p85 subunit of phosphatidylinositol-3-kinase, and
anti-perilipin from Upstate Biotechnology (Lake Placid, NY); anti-
acetyl-coenzyme A-carboxylase, IRS-1, Akt, phospho-Akt(Ser473),
phospho-Akt(Thr308), phospho-MAPKp44/p42 (Thr202/Tyr204),
GSK-3, phospho-GSK3(Ser21), PKC, and phospho-PKC(Thr410) from
Cell Signaling Technology (Beverly, MA); anti-c-Cbl from Santa Cruz Bio-
technology (SantaCruz, CA); anti-GLUT1 fromAlphaDiagnostic Interna-
tional Inc. (SanAntonio, TX); anti-FATP1 and anti-FATP4 supplied byDr.
A. Stahl (Palo Alto Medical Foundation, Palo Alto, CA); anti-FAT/CD36
suppliedbyDr.W.Stremmel(Ruprechts-Karls-University,Heidelberg,Ger-
many); anti-LPL supplied by Dr. J. Peinado (Barcelona University, Barce-
lona, Spain); and anti-SSAO supplied byDr. S. Jalkanen (TurkuUniversity,
Turku, Finland). Alexa555-CtxB, LysoTrackerRed, andAlexa555-human
transferrin were fromMolecular Probes (Invitrogen, Barcelona, Spain).
3T3-L1 cell culture
3T3-L1 fibroblasts (CCL92.1;AmericanTypeCultureCollection,Ma-
nassas, VA) were induced to differentiate into adipocytes essentially as de-
scribed (27) Cells were used 8–11 d after initiation of differentiation.
Design and subcloning of small interfering RNA (siRNA)
On the basis of the established characteristics of siRNA-targeting
constructs described byDr.D. Trono (www.tronolab.com),we designed
a caveolin-1 siRNA duplex corresponding to bases 301-319 from the
open reading frame of the murine caveolin-1 mRNA: 5-AACCA-
GAAGGGACACACAG-3. The scrambled sequence used as a negative
control for siRNA activity was 5-AAAACCGAAGACAGACGGC-3.
siRNA sequence templates were inserted into human H1 promoter
containing pLVTHM lentiviral vector, as described by Dr. D. Trono
(http://tronolab.epfl.ch). Each hairpin consisted of a MluI site, a 19-
nucleotide sense sequence, a short spacer (TTCAAGAGA), a 19-nucle-
otide antisense sequence, five thymidines (a STOP signal for RNA poly-
merase III), andaClaI site.Weconstructeda siRNAformouse caveolin-1
(sicav1) and a control siRNA (scrambled) that does not affect anymurine
protein using oligo pairs (sense and antisense strands are underlined;
italics indicate loop): sicav1, ACGCGTCCCCAACCAGAAGGGACA-
CACAGTTCAAGAGACTGTGTGTCCCTTCTGGTTTTTTTGGAAA-
TCGAT, and scrambled, ACGCGTCCCCAAAACCGAAGACAGACGG-
CTTCAAGAGAGCCGTCTGTCTTCGGTTTTTTTTTGGAAATCGAT.
Lentivirus production and infection of 3T3-L1
preadipocytes
All HIV-1-derived lentiviral constructs (pLVTHM transfer vector,
pCMV8,74 helper packaging construct and pMD2G vector encoding
for envelope protein) were kindly provided by Dr. D. Trono from the
Ecole Polytechnique Federale de Lausanne (Switzerland). The pLVTHM
allows siRNA expression under H1 promoter, and it also contains a
green fluorescent protein (GFP) expression cassette. Lentiviruses encod-
ing scrambled and caveolin-1 siRNA were produced by triple transient
transfectionofHEK293T (28). 3T3-L1preadipocytes grownon six-well
plates were transduced at 60 multiplicity of infection, and cells were
amplified during 5–7 d. Transduced cells (GFP-positive) expressing sim-
ilar levels of GFP protein were then sorted with aMoFlo flow cytometer
(DakoDiagnostics SA,Barcelona, Spain; Submmit version3.1 software),
obtaining 95–99% GFP-positive cells.
Triton X-100 and sucrose density gradient fractionation
of lipid rafts/caveolae
The experiments were performed as previously described (29). For
detection of glycosphingolipid monosialotetrahexosylganglioside (GM1),
10 l of each fraction from the density gradient centrifugation were dot-
blotted onto Hybond C membrane (Bio-Rad Spain, Madrid, Spain) and
incubatedwith horseradish peroxidase-conjugated cholera toxin subunit B
(Sigma-Aldrich, Madrid, Spain).
PM lawn (PML) techniques and immunofluorescence
staining analysis
PML were prepared as described previously (30) and adapted for
3T3-L1 adipocytes as described previously (20). Immunofluorescence and
immunogold techniqueswere adapted using an anti-GLUT4polyclonal an-
tibody (OSCRX) and an anti-caveolin-1 polyclonal antibody. For immu-
nofluorescence staining, we used goat antirabbit-Alexa568 (Molecular
Probes) as secondary antibody.
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For GLUT4 colocalization studies, we incubated control and caveo-
lin-1 KD adipocytes with 50 nMLysoTracker or with 1g/ml Alexa555-
human transferrin for 1 h at 37C.Cellswere then fixed, andGLUT4was
immunolocalized. Quantitative colocalization analyses were performed
using Huygens Essential software (IZASA SA, Madrid, Spain). Colocal-
izationwas analyzedwithin the entire images. The same threshold values
were used for all images. Manders’ M1 and M2 colocalization coeffi-
cients were calculated.
Fluorescence recovery after photobleaching (FRAP)
imaging and data analysis
FRAP experiments were carried out using a Leica TCS SP5 laser
scanning confocal spectral microscope (Leica Microsystems Heidelberg
GmbH,Mannheim, Germany). 3T3-L1 adipocytes were incubated with
1g/mlAlexa555-CTxB (MolecularProbes Invitrogen) at 4C for30min
and washed in PBS. FRAP experiments were performed at 20 C and 5%
CO2 to reduce internalization. For visualization of Alexa555, images
were acquiredusing63PLAPOglycerol immersionobjective (NA1.3),
561-nm laser line, acousto-optical beam splitter 571–650 nm, and the
confocal pinhole set at 1.5 Airy units.
For FRAP experiments of Alexa555-CTxB in 3T3-L1 adipocytes, 10
single scans, prebleach, were acquired at 500-msec interval followed by 14
bleach scans (280-msec interval) at full power laser line (514 and 561 nm)
using a rectangular area of 2 6.5 m. Bleaching region was placed in the
peripheral rimof the labeledadipocyte. In thepostbleachperiod,100images
wereacquiredat500-msec interval followedby140 imagesacquired at 1-sec
intervals, time to enable fluorescence to reach equilibrium. For pre-
and postbleach imaging, excitation intensity was attenuated with
acousto-optical tunable filter to 3–7% of the line laser power to avoid
significant photobleaching, and images were acquired at 1000 Hz
(bidirectional) in a 512- 512-pixel format, pixel size 160 160 nm.
Mean fluorescence intensity in regions of interest during the time
series were quantified using the Image Processing Leica Confocal soft-
ware. Background fluorescence was measured in a random field outside
of the cells and subtracted from all measurements. A neighbor cell total
fluorescence was determined for each image and compared with the
initial cell fluorescence to correct for signal loss during imaging.
For each time point, the fluorescent intensity in the region of interest
was background subtracted, corrected, and finally normalized (accord-
ing to Ref. 31). Fitting of curves was performed with GraphPad Prism
software version 3.0 (GraphPad Software, San Diego, CA) assuming a
one-phase exponential (from bottom, then increase to top) equation: Y
(fluorescence recovery) bottom (top bottom) [1 exp(KX)].
Preparation of carbon-platinum replicas of the inner cell
surface
Replicas were obtained as described previously (30). For immuno-
gold assays, replicas were not digested with household bleach; instead,
they were washed in distilled water for 4 d to preserve the colloidal gold
attached to the replicas (21).
Conventional transmission electron microscopy
The 3T3-L1 adipocytes were processed as described previously (21).
Oil red O staining of trigliceryides
The3T3-L1adipocyteswere fixedwith3%paraformaldehyde for 15
min and then stained with Oil red O for 1 h followed by washing with
70% methanol and water (32).
Measure of glucose uptake and GLUT4 endocytosis
2-D-Deoxyglucose uptake measurements were performed as de-
scribed previously (33).
Phosphotyrosine proteins immunoprecipitation: analysis
of IR, IRS-1, and c-Cbl tyrosine phosphorylation
Control and caveolin-1 KD 3T3-L1 adipocytes were starved for 2 h
in high-glucose DMEM/0.2% BSA and were then incubated for 5 min
with 100 nM insulin. Cells were washed with ice-cold PBS and lysed in
1% Igepal buffer [50mMHEPES (pH7.4), 10mMEDTA, 150mMNaCl,
10 mM sodium pyrophosphate, 100 mM sodium fluoride, 1 mM sodium
vanadate, and a tablet of C-complete (Roche Diagnostics, Sant Cugat,
Spain) protease inhibitor cocktail]. Cell lysates (500 g) were immu-
noprecipitatedwith anti-phosphotyrosine antibody and processed for
Western blot analysis using anti--subunit of IR antibody, anti-IRS-1,
and anti-c-Cbl antibodies.
Measurement of IR and GLUT4 turnover
Cells in a 60-mmdishwerewashed and incubated inmethionine-free
DMEMfor 30min at 37C, followedbypulse labeling inmethionine-free
DMEM containing 10% dialyzed fetal bovine serum and 110 Ci/dish
of [35S]methionine (Perkin Elmer España, Madrid, Spain) for 12 h. The
cells were washed with PBS and incubated in complete DMEM supple-
mented with 10% fetal bovine serum and 100 g/ml L-methionine.
The labeled cells were washed with ice-cold PBS and lysed with 1 ml
lysis buffer (150 mmol/liter NaCl; 1.0% Nonidet P-40; 0.1% sodium
dodecyl sulfate; 1 mmol/liter EDTA/Na; and 50 mmol/liter Tris/Cl, pH
8.0). The lysates were immunoprecipitated with anti-GLUT4 or anti-IR
antibody and analyzed as described previously (34).
Cell fractionation
Cell fractionation was performed as described previously (35).
RNA expression studies
Total RNA extraction and treatment with deoxyribonuclease I were
donewith Trizol reagent (Invitrogen). Total RNA from3T3-L1 adipocytes
at were kept at 80 C until further assay. RNA concentration was deter-
mined by spectrophotometry at an absorbance of 260 nm. Real-time PCR
was performed from 0.1 g total RNA from adipocyte cells, as described
previously (36).Cyclophilin or aRP (acidic ribosomal protein)mRNAwere
assayed as controls in real-time PCR assays. The following primers were
used: caveolin-1 forward AACATCTAC AAGCCCAACAACAAGG and
reverse GGTTCTGCAATCACATCTTCAAAGTC, caveolin-2 forward
ATGACGCCTACAGCCACCACAG and reverse GCCTAGCTT
GAGATGAGAGTTGAG, perilipin forward TGCTGGATGGAgACCTC
and reverseACCGGCTCCATGCTCCA, aP2 forwardTTCGATGAAAT-
CACCGCAGA and reverse GGTCGACTTTCCATCCCACTT, HSL for-
ward GGCTTACTGGGCACAGATACCT and reverse CTGAAG-
GCTCTGAGTTGCTCAA, LPL forward AGG ACCCCTGAAGACAC
and reverse GGCACCCAACTCTCATA, CD36 forward GATGTG-
GAACCCATAACTGGATTCAC and reverse GGTCCCAGTCTCATT-
TAGCCACAGTA, GLUT1 forward CCCCCGCTTCCTGCTCATC and
reverse CTGCCGACCCTCTTCTTTCATC TC, cyclophilin forward
CTTTGACTTGCGGGCATTTTAC and reverse AAGAACTTCAGT-
GAGAGCAGAGATTACAGG, and aRP forward AAGCGCGTCCTG-
GCATTGTCT and reverse CCGCAGGG GCAGCAGTGGT.
Results
Lentivirus-mediated siRNA expression efficiently blocks
caveolin-1 in 3T3-L1 preadipocytes and adipocytes
To selectively knock down the expression of caveolin-1 pro-
tein in 3T3-L1 adipocytes, we obtained 3T3-L1 cell lines with a
reduced expression of caveolin-1 using a pLVTHM lentiviral
vector expressing a siRNA fragment for murine caveolin-1. A
scrambled sequence was also used as negative control. We in-
fected 3T3-L1 preadipocytes, as described in Materials and
Methods. Several infections were performed to rule out artifac-
tual phenotypes, and several 3T3-L1 cell lines expressing caveo-
lin-1 siRNA (sicav1) or scrambled siRNA (control) were gener-
ated and analyzed.
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Caveolin-1 expression in sicav1-infected 3T3-L1 preadipo-
cyteswas dramatically reduced (97%) (Fig. 1A). This decrease in
expressionwas also detected inmature 3T3-L1 adipocytes (95%
reduction) (Fig. 1B). In addition, we analyzed the abundance of
caveolin-1 in the PM by immunolocalization on PML from con-
trol or caveolin-1 KD adipocytes. Data indicate that caveolin-1
was barely detectable on PM of sicav1-infected adipocytes com-
pared with the control group (Fig. 1C).
Caveolin-1 KD causes the ablation of caveolae in
adipocytes
As a first approach, to corroborate that deficiency in caveo-
lin-1 induces caveolae ablation, we obtained ultrathin resin sec-
tions from control and caveolin-1 KD adipocytes (Fig. 1, D and
E). A smaller number of caveolae were observed in the PM of
caveolin-1 KD adipocytes than in PMof control adipocytes, and
in fact, the few caveolae detectable in caveolin-1 KD cells were
isolated, and no caveolae bunches were shown (Fig. 1E). Caveo-
lin-1-depleted adipocytes showed a marked reduction (80%) in
cavin expression (data not shown).
Next, we characterized PMLat the electronmicroscope level.
To this end, membranes were fixed with glutaraldehyde, and
after washing with water and methanol as cryoprotectant, they
were rapidly frozen against a copper block cooled by liquid ni-
trogen. PMLwere then freeze-dried in a freeze-etching unit, and
rotatory replicas of platinum-carbon were obtained following
the Heuser and Anderson technique (30). The replicas showed
inner surfaces of PM clean of cytoplasmic organelles, except for
cytoskeletal elements (Fig. 1, F and G). Clathrin-coated pits and
flat clathrin lattices were observed in PML from control and
caveolin-1 KD adipocytes. The PMof the latter showed very few
FIG. 2. Lipid raft markers in caveolin-1 KD cells are reorganized in dynamic PM
microdomains. A, Control and caveolin-1 KD adipocytes were subjected to
subcellular fractionation using 1% Triton X-100 extraction and
ultracentrifugation in a discontinuous sucrose gradient. An aliquot of each
fraction was dot-blotted and incubated with horseradish peroxidase-conjugated
CTxB or resolved by SDS-PAGE and analyzed by Western blot with specific
antibodies as shown. B, Selected images from a confocal FRAP experiment in
control and caveolin-1 KD adipocytes labeled with Alexa555-CTxB at 20 C. Bar, 5
m. C, Kinetics of recovery for Alexa555-CTxB; each curve shows the mean 
SEM from eight cells from a single experiment. The calculated mobile fractions
were as follows: control adipocytes, 7.2  0.8%; and caveolin-1 KD adipocytes,
43  3.7%.
FIG. 1. siRNA mediated down-regulation of caveolin-1 expression in 3T3-L1
adipocytes and causes caveolae ablation. A, 3T3-L1 preadipocytes were infected
with 60 multiplicity of infection of scrambled or caveolin-1 siRNA (sicav1)
lentivirus. Infected cells were selected as explained in the Materials and Methods
and lysed. Different quantities of protein (prot) from cell lysates were used to
analyze caveolin-1 expression by PAGE and Western blot with an anti-caveolin-1
antibody. B, Different quantities of protein lysates obtained from adipocytes
differentiated from scramble and sicav1 preadipocytes were analyzed as in A.The
same was done with adipocytes differentiated from preadipocytes described in A
and from noninfected preadipocytes (3T3-L1). C, PML were obtained from
adipocytes expressing scrambled or caveolin-1 (sicav1) siRNAs as described in
Materials and Methods and were used to immunolocalize caveolin-1. Images
were obtained with a confocal microscope using Alexa568 secondary antibody.
Bar, 25 m. D,Transmission electron microscopy was used to visualize caveolae
on the PM of ultrathin sections from D control (scrambled siRNA infected) (D)
and caveolin-1 KD (caveolin-1 siRNA infected) (E) adipocytes. Arrows show
caveolae bunches, and arrowheads show individual caveolae. Replicas of PML
from control (F) and caveolin-1 KD (G) adipocytes obtained by freeze-drying
technique were used to visualize and quantify caveolae. Caveolin-1 was
immunolocalized with an anti-caveolin-1 polyclonal antibody and a 15-nm
colloidal gold goat antirabbit secondary antibody on PML from control (H) and
caveolin-1 KD adipocytes (I).
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caveolae.Thenumber of caveolae/m2 SEM calculated from30
micrographs of PML samples were 74.8  10 and 4.06  1.41
in control and caveolin-1 KD adipocytes, respectively. This ob-
servation indicates a 95%reduction in the number of caveolae in
caveolin-1 KD cells, which is parallel to the global caveolin-1
abundance.
When we immunolabeled caveolin-1 on PML before freezing
them (Fig. 2, C and D), in control adipocytes, caveolin-1 local-
ized on caveolae. However, caveolin-1 was associated mostly
with planar parts of the PM in caveolin-1 KD adipocytes (Fig. 1,
H and I). Taken together, these results provide compelling evi-
dence that caveolin-1 siRNA sequences block the expression of
caveolin-1 protein and lead to ablation of caveolae on the cell
surface. Thus, caveolae formation requires the expression of
caveolin-1 in adipocytes.
Lipid raft markers in caveolin-1 KD cells are reorganized
in dynamic PM microdomains
Caveolaeareasubtypeof lipid raft characterizedby thepresence
of caveolin-1. Both caveolae and lipid rafts have a distinctive lipid
composition, in that they are enriched in cholesterol and sphingo-
lipids and therefore characterized by a low buoyant density, which
facilitates their subcellular fractionation.On thebasis of prior data,
wenextanalyzed theabundanceanddistributionof lipid raftmark-
ers, such as cholera toxin B subunit (CTxB), that
binds to GM1 glycosphingolipid, caveolin-1, flo-
tillin-1, and fatty acid transporter (FAT)/CD36 in
control and caveolin-1 KD adipocytes. To this
end, we homogenized adipocytes at 4 C in the
presence of 1% Triton X-100. This method has
been widely used to isolate lipid raft fractions and
preserves their structure and components (37).
GM1 and protein markers of lipid rafts (flotil-
lin-1 and FAT/CD36) were localized in the same
gradient fractions in control and caveolin-1KDadi-
pocytes (Fig. 2A). Transferrin receptor fraction-
ation on sucrose gradient was used as a negative
control of a protein widely described to be absent in
lipid rafts/caveolae. In addition, the abundance of
all these markers was similar in both cell types. The
same results were obtained when we isolated lipid
rafts using an extraction with sodium carbonate at
pH 11 in the absence of detergents, as described
previously (38) (data not shown).
We measured diffusional mobility of raft-asso-
ciated lipids using FRAP experiments in control and
caveolin-1 KD adipocytes labeled with Alexa555-
CTxB at 20 C. In these experiments, we photo-
bleached an area of the rim of adipocyte PM using
high-intensity laser, and the diffusive exchange of
photobleached CTxBwith nearby unbleachedmol-
ecules was then followed for 200 sec (Fig. 2, B and
C). Recovery into the bleached region was higher in
caveolin-1 KD adipocytes than in control adipo-
cytes. The mean mobile fraction (Mf) values SEM
calculated from two independent experiments (n
14 cells) were 8 0.8 and 42 2.7% in control and
caveolin-1 KD adipocytes, respectively. Mf reports the fraction
of fluorescent molecules that were able to recover into the
bleached area over the time course of the experiment.
Deficiency in caveolin-1/caveolae causes a specific
repression of GLUT4 and IR proteins
Caveolae number and caveolin-1 protein expression are
strongly increased during adipogenesis (3, 4). Thus, we studied
the effect of caveolin-1 KD on 3T3-L1 adipocyte differentiation.
Nodifferenceswere detected in themorphology of differentiated
adipocytes (Fig. 3A), the appearance of lipid droplets (Fig. 3B),
or the triglyceride content in cell lysates (mean values expressed
innanomolespermicrogramprotein SEMwere0.420.02and
0.45  0.05 in control and caveolin-1 KD adipocytes, respec-
tively) in response to caveolin-1 repression.We also analyzed the
expression of protein markers characteristic of mature adipo-
cytes such as semicarbazide-sensitive amino-oxidaze, acetyl-co-
enzymeA-carboxylase, perilipin, lipoprotein lipase, FAT/CD36,
FATP1,FATP4, IR, andGLUT4(Fig. 3C).Mostof theseproteins
did not undergo any changes in response to caveolin-1 repres-
sion. However, GLUT4, IR, and caveolin-2 were markedly
down-regulated in caveolin-1 KD adipocytes (Fig. 3C). Caveo-
lin-2 protein stability has been widely reported to depend on
caveolin-1 expression (39, 40), and as a result, caveolin-1-defi-
FIG. 3. Effect of caveolin-1 deficiency on adipocyte and morphology: specific repression of GLUT4
and IR proteins. A and B, Control and caveolin-1 KD adipocytes 10 d after the induction of
differentiation were stained with Oil red O (A) (bar, 40 m) or subjected to immunofluorescence
using an anti-perilipin (B) (bar, 25 m). C, 3T3-L1 adipocytes not infected (3T3-L1) or infected with
scramble (control) or sicav1 lentivirus (caveolin-1 KD) on d 10 after the induction of differentiation
were lysed, and 20 g cell lysates were resolved by SDS-PAGE and analyzed by Western blot with
specific antibodies, as shown. LPL, Lipoprotein lipase; SSAO, semicarbazide-sensitive amino-oxidase.
D, Densitometric analyses from immunoblot data show levels of GLUT4 and IR expression in control
(black bars) and caveolin-1 KD (gray bars) adipocytes. Each data point represents the mean SEM
derived from seven independent experiments. Student’s t test was performed between caveolin-1 KD
and control cells. ***, P 0.005. E, Control (black bars) and caveolin-1 KD (gray bars) adipocytes
were lysed, and mRNA levels of several markers of mature adipocytes were measured by real-time
RT-PCR as described inMaterials and Methods.
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cient cells also lack caveolin-2. GLUT4 and IR expression was
diminished by 50 and 40%, respectively, in caveolin-1 KD adi-
pocytes (Fig. 3D).
Real-time PCR analysis of the levels of mRNA for several
genes in adipocytes revealed normal expression in caveolin-1-
deficient adipocytes (Fig. 3E). These data suggest that caveolin-1
deficiency is linked to a translational or posttranslational defect
for GLUT4 and IR expression.
Adipocytes deficient in caveolin-1/caveolae show
reduced insulin-stimulated glucose transport
Next, we studied the activation of insulin signaling pathway
by analyzing the phosphorylation of a number of intermediates
described to participate in the classical phosphatidylinositol
3-kinase-dependent pathway [IRS-1, Akt, and protein kinase
C (PKC)] (41, 42) and in the caveolae-associated Cbl/TC10
pathway (c-Cbl) (16, 43).We also examined insulin activation
of MAPK and glycogen synthase kinase-3. Insulin-stimulated
IR tyrosine phosphorylation was lower in caveolin-1 KD adi-
pocytes compared with control cells (Fig. 4A). Under these
conditions, insulin-stimulated phosphorylation of IRS-1, Akt,
PKC, glycogen synthase kinase-3, MAPK or c-
Cbl was normal (Fig. 4A).
Measurement of 2-D-deoxy[3H]glucose uptake
revealed a marked reduction of insulin-stimulated
glucose transport (50%reduction) in caveolin-1-de-
ficient adipocytes compared with control cells (Fig.
4B). Under these conditions, basal glucose transport
was unaltered (Fig. 4B). Reduced insulin-stimulated
glucose uptakewas explained by a lowered transloca-
tion of GLUT4 to the PM in adipocytes (Fig. 4D).
We also studied the insulin sensitivity of caveo-
lin-1 KD adipocytes by measuring 2-deoxyglucose
uptakeat a rangeof insulin concentrations (Fig. 4C).
Estimation of insulin EC50 values revealed that
caveolin-1 KD cells were less insulin sensitive than
control adipocytes (EC50 values were 0.31 and 0.71
nM in control and caveolin-1KDadipocytes, respec-
tively). In all, our data indicate that specific defi-
ciency in caveolin-1/caveolae reduces IR function,
and this, together with the reduced GLUT4 ex-
pression, causes insulin resistance in adipocytes,
which is characterized mainly by a reduced max-
imal response to insulin.
Caveolin-1/caveolae deficiency reduces the
half-lives of GLUT4 and IR proteins
To determine the mechanisms by which caveo-
lin-1 deficiency caused down-regulation of IR and
GLUT4, we analyzed GLUT4 and IR protein turn-
over in control and caveolin-1 KD adipocytes.
[35S]Methionine pulse-chase analysis revealed a sig-
nificant increase in IR (Fig. 5A) and GLUT4 (Fig.
5B) degradation in the absence of caveolin-1.Quan-
tification of four independent experiments was per-
formed in cells to estimate protein half-lives. Data
indicated that the half-life of IRwas 6.3 h in control
adipocytes and 2.7 h in caveolin-1 KD adipocytes. GLUT4 half-
life was 36 and 22 h in control and caveolin-1 KD adipocytes,
respectively. In all, caveolin-deficient adipocytes showed a faster
degradation of IR and GLUT4 proteins.
Caveolae are not essential for GLUT4 internalization
after insulin removal
Our group has reported that lipid rafts are required for
GLUT4 internalization after insulin washout in adipocytes and
that a substantial percentage of GLUT4 is localized in caveolae
(21). In adipocytes, 30% of the PM surface are caveolae (3), so
the vast majority of lipid rafts are caveolae. In caveolin-1 KD
adipocytes, caveolae, but not lipid rafts, disappeared from the
PM. Thus, we studied whether GLUT4 internalization, which is
active after insulin removal, is affected by the lack of caveolae.
GLUT4 abundance in PML was higher in insulin-treated cells
than in cells in the basal state in both control and caveolin-1 KD
adipocytes (Fig. 6A). As expected, PML from control adipocytes
showed greater GLUT4 expression levels than caveolin-1-defi-
cient adipocytes (Fig. 6A). Fifteenminutes after insulin removal,
GLUT4 was reduced at the cell surface (Fig. 6A). However,
FIG. 4. Analysis of insulin pathway activation and plasma membrane GLUT4 translocation. A,
Control and caveolin-1 KD adipocytes were incubated with () or without () 100 nM insulin for
5 min. Cells were lysed, and 1 mg cell extract was used for immunoprecipitation with an anti-
phosphotyrosine antibody. Immunoprecipitates were blotted with anti-IRS-1 antibody (P-IRS-1),
anti-c-Cbl antibody (P-c-Cbl), or anti-IR -subunit (P-IR). Cell lysates (100 g) were also resolved
by SDS-PAGE and analyzed by Western blot using specific antibodies as shown. Left panels show
phosphorylation of insulin signaling pathway proteins, and right panels show total expression of
these proteins. GSK3, Glycogen synthase kinase 3; P-GSK3, phospho-GSK3; P-MAPK-p44/42,
phospho-MAPK-p44/42 P-pKC, phospho-pKC. B, Control and caveolin-1 KD adipocytes were
treated (gray bars) or not (black bars) with 100 nM insulin for 30 min, and glucose uptake was
measured by 2-deoxy-[3H]glucose (2DG) uptake in 5 min. Student’s t test was performed
between caveolin-1 KD and control cells. ***, P  0.005. C, Control (F) and caveolin-1 KD (‚)
adipocytes were treated with a range of insulin concentrations (10 and 100 pM and 1, 10, 50,
and 100 nM) for 30 min, and 2DG uptake was measured as in B. Graph shows the mean  SEM
derived from seven independent experiments. Two-way ANOVA indicated significant differences
between the control and the caveolin-1 KD groups at P  0.01. D, GLUT4 translocation to PM
after insulin stimulation. Control and caveolin-1 KD adipocytes incubated in the presence () or
absence () of 100 nM insulin for 30 min were subjected to subcellular fractionation as explained in
Materials and Methods. PM (15 g) and low-density membranes (LDM) were resolved by SDS-PAGE
and analyzed by immunoblots using specific antibodies against GLUT4, caveolin-1, and flotillin-1.
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caveolin-1 deficiency did not block the internalization of
GLUT4. Fluorescence intensity of GLUT4 on PML was deter-
mined by confocal microscopy (using the fluorescence intensity/
pixel area). We analyzed the decrease of GLUT4 signal on the
PML of adipocytes 15 min after the removal of insulin, and we
quantified a reduction of GLUT4 staining of 28 5% (SEM) and
25  5% (SEM) in control and caveolin-1 KD adipocytes,
respectively.
To further analyze the effect of caveolaedeficiencyonGLUT4
internalization induced by insulin removal, we assayed the
down-regulationof2-deoxyglucose transport after insulinwash-
out (Fig. 6B). To this end, adipocytes were initially stimulated
with insulin for 30min, washed at pH6.0 to remove insulin, and
incubated at 37 C for a range of times up to 30 min. This pro-
cedure has been previously used to shut off insulin action (33).
We estimated the decrease in 2-deoxyglucose uptake and fitted
the regression curve of GLUT4 internalization over time. The
lackof caveolin-1didnot significantly alter this process (Fig. 6B).
To further analyzeGLUT4 localization,we incubated control
and caveolin-1KDadipocyteswith 50 nMLysoTracker (Fig. 6C)
or with 1g/ml Alexa555-human transferrin (Fig. 6D) for 1 h at
37 C. Quantitative colocalization analyses were performed
using Huygens Essential software (IZASA SA). Manders’ co-
localization coefficients were calculated; GLUT4 colocalization
with transferrin was 0.335 0.021 and 0.296 0.026 for con-
trol and caveolin-1KDadipocytes, respectively (differenceswere
not significant). GLUT4 colocalization with Lysotracker was
0.041  0.007 and 0.138  0.0026 for control and caveolin-1
KD adipocytes, respectively. These data indicate that colocal-
ization of GLUT4 with the lysosomal marker was increased in
caveolin-1 KD adipocytes. This finding suggests that one of the
pathways involved in the increased degradation ofGLUT4 in the
absence of caveolin-1/caveolae is lysosomal. However, when we
assessed the overlap of GLUT4 and the endosomal
marker transferrin receptor, we did not observe
any difference between control and caveolin-1 KD
adipocytes.
Discussion
In this study, we have shown that the decrease in the
expression of caveolin-1 in 3T3-L1 adipocytes leads
to a concomitant reduction in the number of caveo-
lae on the PM. This effect promotes a diminished
expression of IR and GLUT4 in caveolin-1 KD adi-
pocytes,which is due to a faster degradation of these
proteins and not to a defect in gene expression or
adipocyte differentiation. Caveolin-1-deficient adi-
pocytes show reductions in insulin-stimulated glu-
cose transport, insulin-triggered GLUT4 transloca-
tion to the cell surface, and IR activation.
Caveolae and noncaveolar lipid rafts are mem-
brane lipid microdomains with similar lipid com-
position (44, 45). The major difference between
these two structures is the main protein component
of caveolae, caveolin, which give caveolae their in-
vaginated shape. The large abundance of caveolae in specific cell
types, such as smooth muscle cells, fibroblasts, endothelial cells,
and adipocytes, has motivated us to investigate the role of this
structure in each cell type. The 3T3-L1 adipocytes are a cell line
with major caveolae abundance in the PM. This feature corre-
sponds with the high expression of caveolin-1 in these cells,
which is notably increased during adipogenesis. Most of the
methods that have been used to abolish caveolae, and therefore
study their function is based on cholesterol depletion or capture,
thus disturbing caveolae and lipid rafts (46). In this regard, we
have analyzed the effect of specific ablation of caveolae from the
PM. Lipid and protein markers of caveolae (flotillin and FAT/
CD36), still remained in low-density membranes in the absence
of caveolae, and their expression was not reduced as assessed by
subcellular fractionation. In embryonic fibroblasts of caveolin-1
knockout (KO) mice, it has been shown that FAT/CD36 is re-
distributed to detergent-soluble membranes (47) in contrast to
what we have described in caveolin-1 KD adipocytes.
FRAP experiments performed in control adipocytes indicated
that Alexa555-CTxB-labeled membrane microdomains were
highly immobile (8%), comparable to previously reported sta-
bility of caveolin-1 in caveolae (48). The lowdiffusionalmobility
of CTxB in control adipocytes, resembling that of caveolae
markers, suggests that GM1 mainly localizes in caveolae. How-
ever, in caveolin-1 KD adipocytes, devoid of caveolae, FRAP
experiments showed that themobility of Alexa555-CTxB in PM
was increased (42%), suggesting that GM1 redistributed to
membrane microdomains more dynamic than caveolae. This
change inmobility can be produced by caveolin-1 loss; however,
it cannot be ruled out that a change in lipid composition of these
microdomains is also produced.We have not studied the specific
order and compositionproperties of adipocytemembranes in the
presence or absence of caveolin-1 to identify the kind of trans-
FIG. 5. IR and GLUT4 half-lives are reduced in caveolin-1-deficient adipocytes. Control and
caveolin-1 KD 3T3-L1 adipocytes were pulse labeled with [35S]methionine for 12 h. Adipocytes
were washed and chased in fresh medium for the indicated periods. At the end of the
incubation, IR (A) or GLUT4 (B) was immunoprecipitated from the cell lysates and subjected to
autoradiography as described in Materials and Methods. A control lane immunoprecipitated
without antibody (NoAb) is also shown. Left panels show representative autoradiogram data.
Right panels show 35S radioactivity in the IR (A) or GLUT4 (B) bands expressed as the percentage
of the initial value. Results are shown as the mean  SD (n  4). Two-way ANOVA indicated
significant differences between the control and the caveolin-1 KD groups, at P  0.05.
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formation that caveolae undergo when they are depleted of
caveolin-1 and the implications of these.
Nevertheless, caveolin-1 absence has an important effect on
adipocyte physiology. Caveolin-1-depleted preadipocytes be-
come differentiated to adipocytes, but they show a considerable
decrease in GLUT4 and IR protein expression, and this effect is
due mainly to a reduction in the half-life of the transporter. The
results suggest that most of the GLUT4 protein repression (but
probably not thewhole component) is explained by an enhanced
rate of degradation. This observation suggests that caveolin-1/
caveolae act as a stabilizer of GLUT4 and IR by preventing their
degradation.We cannot exclude that caveolae structure or other
components of caveolae, such as cavin, are responsible for these
effects. Recently, Pilch’s group (11) has shown that cavin KO
mice, that lack caveolae in all cell types, also show a marked
reduction of GLUT4 and IR expression in adipose tissue. In this
cavin KO mouse, caveolin-1 expression is also decreased, the
same as what happens when cavin expression is decreased in
3T3-L1 adipocytes (10). We have also found that caveolin-1
reduction leads to a decrease in cavin expression (data not
shown). Thus, these results show that caveolae components are
related.
Caveolin-1/caveolae could act as directing protein/organelle
with a relevant role in determining the intracellular fate of IR and
GLUT4. Caveolin-1/caveolae could favor intracellular recycling
andpreventGLUT4and IRdegradation. Faster proteosomedeg-
radation of IR in adipose tissue has been previously described in
caveolin-1 knockout mice (13). However, these mice present
hyperinsulinemia and it has been largely documented that hy-
perinsulinemia can increase IR degradation
(50–54). Nevertheless, caveolin-1 knockout
mice show GLUT4 overexpression in adi-
pose tissue (13). However, this effect could
again be explained by long exposure to high
levels of insulin, which have been described
to stimulate GLUT4 expression (55–59).
Liao’s group has not described a decrease in
GLUT4 and IR protein expression in their
caveolin-1KD3T3-L1 adipocytes, however,
they have performed their experiments with
two monoclonal stably transfected cell lines
(60, 61). Our data suggest that caveolin-1
reduction increases GLUT4 lysosomal deg-
radation (Fig. 6C) and that this is indepen-
dent of a differential distribution between
endosomes and the insulin-responsive stor-
age compartment (Fig. 6D). This observa-
tion points to an enhanced flux of GLUT4
from endosomes to lysosomes.
Wehave found that caveolin-1KD in adi-
pocytes causes a drop in GLUT4 and IR ex-
pression levels, and under these conditions,
maximal insulin-stimulated glucose trans-
port is markedly reduced, and insulin sen-
sitivity is also diminished. It has previously
been described that rat adipocytes with an
80% decrease in IR expression show a
marked resistance to insulin, althoughmaximal insulin response
is preserved. These data are internally coherent provided that
there are spare receptors in adipocytes (which also includes
3T3-L1 adipocytes), and therefore a decrease in IR reduces in-
sulin sensitivity (62). In contrast, because of the central role of
GLUT4 permitting an optimal insulin response, a reduction in
GLUT4 impacts on maximal insulin-stimulated glucose trans-
port (63).
Our results show that caveolae are not essential for GLUT4
internalization after insulin removal; however, caveolin-1 KD
adipocytes show a 50% reduction in GLUT4 expression. Previ-
ously, by use of cholesterol-chelating agents, we and others have
shown that integrity of lipid rafts is required for GLUT4 inter-
nalization (21, 23). Moreover, it has been shown that GLUT4
endocytosis in 3T3-L1 adipocytes is partially dependant on
caveolae, using a dominant caveolinmutant (22) or in caveolin-1
KD adipocytes (61). Thus, we cannot discard a role of caveolae
in GLUT4 internalization. In this regard, it may be helpful to
examine rates of endocytosis or exocytosis to precisely charac-
terize GLUT4 trafficking and to further address the effect of
caveolin-1/caveolae in the time course and route of GLUT4 in-
tracellular transit.
We consider that the increase inGLUT4degradation can be
explained in the absence of changes in GLUT4 internalization
after insulin removal. Alternatively, GLUT4 degradation
could be due to changes taking place under basal conditions
because it has been described that the mechanisms for inter-
nalization and recycling differ in the basal state and after
insulin removal (49,64,65).
FIG. 6. GLUT4 internalization after insulin removal is not affected by caveolin-1 deficiency. A, PML were
obtained from control and caveolin-1 KD adipocytes in the basal state, after 100 nM insulin treatment for
30 min, and 15 min after insulin washout. PML were stained with an anti-GLUT4 antibody. Bar, 25 m. B,
2-Deoxyglucose (2DG) uptake was measured in control (F) and caveolin-1 KD (‚) adipocytes after insulin
removal at the time points indicated. For this, cells were first treated with 100 nM insulin for 30 min,
washed twice with low pH KRM buffer [20 mM MES (pH 6.0), 120 mM NaCl, 5 mM KCl, 1.2 mM MgSO4,
1.3 mM CaCl2, 1.3 mM KH2PO4, 2 mM sodium pyruvate] to remove insulin and then incubated with 0.2%
BSA-KRM (pH 6) buffer for the indicated times. Then the cells were washed with KRH buffer, and 2-
deoxy-D-[1-3H]glucose uptake was measured as described above. Serum-deprived control and caveolin-1
KD adipocytes were incubated with 50 nM LysoTracker Red (Molecular Probes) (C) or 1 g/ml Alexa555-
human transferrin (D) for 1 h at 37 C. Cells were then fixed, and GLUT4 was immunolocalized using
OSCRX and a cyanine 5-conjugated secondary antibody. Quantitative colocalization analyses were
performed using Huygens Essential software (IZASA SA). Bar, 25 m.
3500 Gonza´lez-Mun˜oz et al. Caveolin-1 Stabilizes GLUT4 and IR Endocrinology, August 2009, 150(8):3493–3502
Herewe demonstrate that caveolin-1 deficiency in adipocytes
has a direct effect on the expression of IR and GLUT4 proteins,
independently of insulin levels, thereby demonstrating a main
role of caveolin-1 in controlling the expression of proteins that
are crucial in states of insulin resistance and obesity.
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